TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/24/23 20:52 | 8/24/23 | GERN | Geron Corp | DE | Health | Drug | Pharmaceutical Preparations | O'Farrell Elizabeth G. | CA | D | P | 30 | 2.28 | 0 | 13 | 65 | 34 | M | |||||||||||||||
11/24/20 19:25 | 11/23/20 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Farrell Elizabeth G. | NV | D | S | -63 | 2.44 | 0 | -26 | -100 | 0 | D | |||||||||||||||
11/20/20 20:22 | 11/18/20 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Farrell Elizabeth G. | NV | D | S | -151 | 2.38 | 0 | -63 | -71 | 26 | D | |||||||||||||||
8/24/20 20:57 | 8/21/20 | GERN | Geron Corp | DE | Health | Drug | Pharmaceutical Preparations | O'Farrell Elizabeth G. | CA | D | P | 30 | 1.73 | 0 | 17 | 793 | 20 | I | |||||||||||||||
1/13/20 21:10 | 1/10/20 | GERN | Geron Corp | DE | Health | Drug | Pharmaceutical Preparations | O'Farrell Elizabeth G. | CA | D | P | 4 | 1.34 | 0 | 3 | New | 3 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |